ACE-031

£69.99
In Stock

ACE-031 is a fusion protein that acts as a myostatin inhibitor. By binding to proteins like myostatin that restrict muscle development, it acts as a “decoy receptor” to promote muscle growth, increase lean body mass, and increase bone density.

  • Fast dispatch on all orders placed Monday–Friday
  • Discreet, tracked packaging on every order
  • Certificate of Analysis available for every batch
  • For laboratory research use only — not for human or veterinary use
  • Customer support available by email for any questions

Description

ACE-031, offered at 1mg, is a high-quality, specialised research peptide developed for advanced scientific exploration in muscle physiology. This product is ideal for laboratory settings where precision and reliability are paramount.

  • Product Name: ACE-031 1mg
  • Catalogue Number: ACE1-024
  • Molecular Formula: C133H227N43O33
  • Molecular Weight: 2956.5 g/mol
  • Purity: 95%
  • Sequence: TBC
  • Form: Lyophilised Solid

Usage and Storage

ACE-031 is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments. For best results, follow our website’s detailed reconstitution and storage guidelines.

Synthesis and Quality Assurance:

ACE-031 is meticulously synthesised through a controlled process that guarantees high purity and stability, making it suitable for precise scientific studies. Our commitment to excellence ensures that each batch undergoes stringent quality control to meet the rigorous standards researchers require.

Legal and Safety Information:

UK-Peptides proudly provides ACE-031 strictly for scientific and research use. In alignment with our dedication to supporting the research community, we ensure our products meet stringent quality standards and legal requirements. Please note that our peptides, including ACE-031, are not designed for human consumption or clinical application.

If you require high-quality ACE-031 for your research in the UK, explore our range of peptides designed for scientific rigour and innovation.